Clinical Trial Update: Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a conditioning regimen combining venetoclax, azacytidine, and a modified BUCY approach for patients with acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN